Toxoplasmosis landscape: a systematic review and meta-analysis of seroprevalence in healthy and non-healthy individuals in Sudan (1990-2025)

弓形虫病概况:苏丹健康人群和非健康人群血清流行率的系统评价和荟萃分析(1990-2025 年)

阅读:2

Abstract

BACKGROUND: Human toxoplasmosis is a widespread zoonotic infection with significant public health implications, particularly in Sudan, where the disease burden is high. However, the overall prevalence of Toxoplasma gondii infection in the country remains unclear. This systematic review and meta-analysis aimed to estimate the pooled seroprevalence of human toxoplasmosis in Sudan and identify associated risk factors. METHODS: A comprehensive search was conducted in English and Arabic databases for studies published before February 28, 2025, following PRISMA guidelines. The meta-analysis included 60 studies with 10,866 participants from different regions of Sudan. RESULTS: The pooled seroprevalence of human toxoplasmosis was 36% (95% CI: 31-41%), with significant heterogeneity (I(2) = 97.29%, P < 0.0001). Hemodialysis patients exhibited the highest prevalence (56%), followed by women of childbearing age (48%) and HIV patients (42%). Geographically, northern Sudan had the highest prevalence (46%), while western Sudan had the lowest (17%). The latex agglutination test (LAT) was the most frequently used diagnostic method (56.7% of cases). Temporal analysis suggested that the prevalence of toxoplasmosis has slightly declined in recent years, likely due to improved hygiene, sanitation, and increased use of antiparasitic treatments. CONCLUSION: Toxoplasmosis remains highly endemic in Sudan, with certain groups-including males, hemodialysis patients, women of childbearing age, HIV patients, and workers exposed to animals-at heightened risk. Targeted public health interventions are necessary to reduce the disease burden among high-risk populations.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。